ALMIGRA 6.25MG TABLET
₹54*
MRP ₹60
10% off
₹51*
MRP ₹60
15% CB
₹9 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
ALMIGRA 6.25MG TABLET belongs to a class of drugs known as 'antimigraine' used to prevent migraine symptoms such as headache, nausea, and vomiting. Migraine is a neurological condition characterized by intense pulsating, throbbing, pounding, debilitating headache, which usually occurs on one side of the head; however, it can occur on both sides or shift. Hormonal changes, stress, bright lights, loud sounds, and certain foods and drinks can trigger migraine headaches.
ALMIGRA 6.25MG TABLET contains Zolmitriptan. It works by acting on the serotonin (5-HT) receptors located in the brain, thereby causing the narrowing of the brain's blood vessels, which affects the blood flow patterns associated with headaches. Thus, ALMIGRA 6.25MG TABLET helps effectively in treating symptoms of migraine-like headache, nausea and vomiting.
Take ALMIGRA 6.25MG TABLET as prescribed by your doctor. Depending upon your medical condition, you are advised to take ALMIGRA 6.25MG TABLET for as long as your doctor has prescribed it for you. In some cases, you may experience certain common side effects such as dizziness, sleepiness, nausea, chest discomfort, dry mouth, irregular heartbeats and heartburn. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Do not take ALMIGRA 6.25MG TABLET if you are pregnant or breastfeeding unless prescribed. ALMIGRA 6.25MG TABLET should not be taken during the third trimester of pregnancy. ALMIGRA 6.25MG TABLET can increase the risk of fatal heart attack or stroke, gastrointestinal bleeding, ulceration and perforation of the stomach and intestines. ALMIGRA 6.25MG TABLET causes drowsiness and dizziness, so drive with caution. ALMIGRA 6.25MG TABLET should not be given to children as safety and efficacy have not been established. Avoid consuming alcohol along with ALMIGRA 6.25MG TABLET as it could lead to increased drowsiness and dizziness. Keep your doctor informed about your health condition and medicines to rule out any side effects.
ALMIGRA 6.25MG TABLET contains Zolmitriptan (anti-migraine medication), which prevents migraine symptoms such as headaches, nausea and vomiting. It works by acting on the serotonin (5-HT) receptors in the brain, thereby causing the narrowing of the brain's blood vessels, which affects the blood flow patterns associated with headaches. Thus, ALMIGRA 6.25MG TABLET helps effectively in treating migraine symptoms like headache, nausea and vomiting.
Do not take ALMIGRA 6.25MG TABLET if you are allergic to any of its contents, if you have had any recent heart surgery or stroke, blood circulation problems, heart problems, narrowing of blood vessels to the stomach, legs, arms or kidneys or uncontrolled high blood pressure. Be cautious as ALMIGRA 6.25MG TABLET can increase the risk of fatal heart attack or stroke, gastrointestinal bleeding, and ulceration. Do not take ALMIGRA 6.25MG TABLET if you are pregnant or breastfeeding unless prescribed. ALMIGRA 6.25MG TABLET should not be taken during the third trimester of pregnancy. ALMIGRA 6.25MG TABLET may cause drowsiness and dizziness, so drive only if you are alert. ALMIGRA 6.25MG TABLET should not be given to children as safety and effectiveness have not been established. Avoid consuming alcohol along with ALMIGRA 6.25MG TABLET as it could lead to increased drowsiness. Stop taking ALMIGRA 6.25MG TABLET and consult your doctor immediately if you have stomach pain or any signs of bleeding in the intestine or stomach, such as blood in stools.
Drug-Disease Interactions: ALMIGRA 6.25MG TABLET may interact with people with renal or liver problems, cardiovascular disease, heart failure, blood clots in the legs, gastrointestinal toxicity, mental illness, and Raynaud's disease (problems with blood flow).
Drug-Food Interactions: Avoid the consumption of alcohol, smoking and caffeinated products. Do not consume St John's Wort plant while taking ALMIGRA 6.25MG TABLET.
Drug-Drug Interactions: ALMIGRA 6.25MG TABLET may have interaction with a blood thinner (warfarin, aspirin), cardiac glycoside (digoxin), anti-psychotic (lithium, alprazolam, escitalopram), anti-depressant (citalopram, duloxetine, fluoxetine, imipramine, nortriptyline), anti-hypertensive (propranolol, metoprolol), stomach ulcer medicine (cimetidine), pain killers (ibuprofen, naproxen).
Migraine: It is a neurological condition that is characterized by an intense, debilitating headache. Hormonal changes, stress, lack or excess of sleep, bright lights, loud sounds, and certain foods and drinks can trigger migraine headaches. Warning symptoms precede migraine headache one or two days before the headache itself. The warning symptoms include food cravings, depression, fatigue, hyperactivity, irritability and neck stiffness. Symptoms of migraine include throbbing pain in one area with varying intensity, nausea, vomiting, numbness or tingling sensation, difficulty speaking, and sensitivity to sound and light.
Alcohol
Caution
Avoid consumption of alcohol while taking ALMIGRA 6.25MG TABLET as it may increase drowsiness.
Pregnancy
Caution
ALMIGRA 6.25MG TABLET should be used during the first and second trimester of pregnancy only on the doctor's prescription and if the doctor thinks the benefits outweigh the risks. ALMIGRA 6.25MG TABLET should not be taken during the third trimester of pregnancy.
Breast Feeding
Caution
ALMIGRA 6.25MG TABLET may pass into breast milk and harm the baby. Please consult your doctor before taking ALMIGRA 6.25MG TABLET, and your doctor will decide whether ALMIGRA 6.25MG TABLET can be taken by breastfeeding mothers or not.
Driving
Caution
ALMIGRA 6.25MG TABLET may cause dizziness and drowsiness. Do not drive or operate machinery unless you are alert.
Liver
Caution
Dose adjustment may be needed in patients with liver impairment. Please consult your doctor if you have a liver impairment or any concerns.
Kidney
Caution
Dose adjustment may be needed in patients with kidney impairment. Please consult your doctor if you have kidney impairment or any concerns.
Children
Caution
ALMIGRA 6.25MG TABLET should not be given to children as the safety and effectiveness were not established.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes